• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于整体健康状况的中度至重度慢性阻塞性肺疾病患者聚类分析确定了三种临床表型:与常规治疗和肺康复相关。

Integral Health Status-Based Cluster Analysis in Moderate-Severe COPD Patients Identifies Three Clinical Phenotypes: Relevant for Treatment As Usual and Pulmonary Rehabilitation.

作者信息

Peters Jeannette B, Boer Lonneke M, Molema Johan, Heijdra Yvonne F, Prins Judith B, Vercoulen Jan H

机构信息

Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.

Department of Medical Psychology, Radboud University Medical Center, Postbus 66, 6560 AB Groesbeek, Nijmegen, The Netherlands.

出版信息

Int J Behav Med. 2017 Aug;24(4):571-583. doi: 10.1007/s12529-016-9622-3.

DOI:10.1007/s12529-016-9622-3
PMID:27995441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5509789/
Abstract

PURPOSE

The purposes of the study are to identify clinical phenotypes that reflect the level of adaptation to the disease and to examine whether these clinical phenotypes respond differently to treatment as usual (TAU) and pulmonary rehabilitation (PR), the latter with its strong emphasis on improving adaptation.

METHODS

Clusters were identified by a cluster analysis using data on many subdomains of the four domains of health status (HS) (physiological functioning, functional impairment, symptoms and quality of life) in 160 outpatients with chronic obstructive pulmonary disease (COPD) receiving TAU. By discriminant analysis in the TAU sample, all 459 PR patients could be assigned to one of the identified clusters. The effect of TAU and PR on HS was examined with paired t tests.

RESULTS

Three distinct phenotypes were identified in the TAU sample. Two types were labelled adapted: phenotype 1 (moderate COPD-low impact on HS, n = 53) and phenotype 3 (severe COPD-moderate impact on HS, n = 73). One type was labelled non-adapted: phenotype 2 (moderate COPD-high impact on HS, n = 34). After 1-year TAU, the integral health status of all patients did not improve in any subdomain. In contrast, at the end of PR, significant improvements in HS were found in all three phenotypes especially the non-adapted.

CONCLUSIONS

Different phenotypes exist in COPD that are based on behavioural aspects (i.e. the level of adaptation to the disease). Non-adapted patient responds better to treatments with a strong emphasis on improving adaptation by learning the patient better self-management skills. Knowing to which clinical phenotype a patient belongs helps to optimize patient-tailored treatment.

摘要

目的

本研究的目的是识别反映疾病适应水平的临床表型,并检查这些临床表型对常规治疗(TAU)和肺康复(PR)的反应是否不同,后者特别强调改善适应性。

方法

使用接受TAU治疗的160例慢性阻塞性肺疾病(COPD)门诊患者健康状况(HS)四个领域(生理功能、功能障碍、症状和生活质量)许多子领域的数据,通过聚类分析确定聚类。通过对TAU样本进行判别分析,可将所有459例PR患者分配到已确定的聚类之一。采用配对t检验检查TAU和PR对HS的影响。

结果

在TAU样本中识别出三种不同的表型。两种类型被标记为适应型:表型1(中度COPD - 对HS影响低,n = 53)和表型3(重度COPD - 对HS影响中度,n = 73)。一种类型被标记为未适应型:表型2(中度COPD - 对HS影响高,n = 34)。经过1年的TAU治疗后,所有患者的整体健康状况在任何子领域均未改善。相比之下,在PR结束时,所有三种表型,尤其是未适应型,HS均有显著改善。

结论

COPD中存在基于行为方面(即对疾病的适应水平)的不同表型。未适应型患者对特别强调通过学习更好的自我管理技能来改善适应性的治疗反应更好。了解患者属于哪种临床表型有助于优化个体化治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/0bcc459bbb18/12529_2016_9622_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/be92672e73d7/12529_2016_9622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/81d032d331cf/12529_2016_9622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/75a51075389c/12529_2016_9622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/0bcc459bbb18/12529_2016_9622_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/be92672e73d7/12529_2016_9622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/81d032d331cf/12529_2016_9622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/75a51075389c/12529_2016_9622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec91/5509789/0bcc459bbb18/12529_2016_9622_Fig4_HTML.jpg

相似文献

1
Integral Health Status-Based Cluster Analysis in Moderate-Severe COPD Patients Identifies Three Clinical Phenotypes: Relevant for Treatment As Usual and Pulmonary Rehabilitation.基于整体健康状况的中度至重度慢性阻塞性肺疾病患者聚类分析确定了三种临床表型:与常规治疗和肺康复相关。
Int J Behav Med. 2017 Aug;24(4):571-583. doi: 10.1007/s12529-016-9622-3.
2
Clinical phenotypes of obstructive airway diseases in an outpatient population.门诊患者群体中阻塞性气道疾病的临床表型
J Asthma. 2016 Dec;53(10):1026-32. doi: 10.3109/02770903.2016.1174258. Epub 2016 Jul 1.
3
A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.一种聚类方法,用于确定和描述哮喘和慢性阻塞性肺疾病重叠表型。
Clin Exp Allergy. 2017 Nov;47(11):1374-1382. doi: 10.1111/cea.12970. Epub 2017 Aug 1.
4
[Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].[采用层次聚类分析和两步聚类分析对症状性慢性气道疾病临床表型的研究]
Zhonghua Nei Ke Za Zhi. 2016 Sep 1;55(9):679-83. doi: 10.3760/cma.j.issn.0578-1426.2016.09.005.
5
Can we identify patients with different illness schema following an acute exacerbation of COPD: a cluster analysis.我们能否识别慢性阻塞性肺疾病急性加重后具有不同疾病模式的患者:一项聚类分析。
Respir Med. 2014 Feb;108(2):319-28. doi: 10.1016/j.rmed.2013.10.016. Epub 2013 Oct 30.
6
Gender considerations in pulmonary rehabilitation.肺康复中的性别因素
J Cardiopulm Rehabil Prev. 2008 May-Jun;28(3):215-9. doi: 10.1097/01.HCR.0000320075.11965.1c.
7
Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.在一个日本慢性阻塞性肺疾病纵向队列中识别出五组共病情况。
Respir Med. 2016 Aug;117:272-9. doi: 10.1016/j.rmed.2016.07.002. Epub 2016 Jul 7.
8
Different short-term and longitudinal results on perceived health status for asthma and COPD patients after pulmonary rehabilitation. Patients living alone have the largest improvements in perceived quality of life.哮喘和慢性阻塞性肺疾病(COPD)患者在肺康复后,其感知健康状况的短期和纵向结果各异。独居患者的生活质量改善最为显著。
Chron Respir Dis. 2008;5(2):69-73. doi: 10.1177/1479972307086724.
9
Effectiveness of pulmonary rehabilitation in COPD with mild symptoms: a systematic review with meta-analyses.轻度症状慢性阻塞性肺疾病患者肺康复的有效性:一项系统评价与荟萃分析
Int J Chron Obstruct Pulmon Dis. 2015 Apr 17;10:791-801. doi: 10.2147/COPD.S78607. eCollection 2015.
10
Home-based neuromuscular electrical stimulation improves exercise tolerance and health-related quality of life in patients with COPD.居家神经肌肉电刺激可改善慢性阻塞性肺疾病患者的运动耐力和健康相关生活质量。
Int J Chron Obstruct Pulmon Dis. 2016 Jun 3;11:1189-97. doi: 10.2147/COPD.S105049. eCollection 2016.

引用本文的文献

1
Computational Phenotyping of Obstructive Airway Diseases: A Systematic Review.阻塞性气道疾病的计算表型分析:一项系统综述
J Asthma Allergy. 2025 Feb 6;18:113-160. doi: 10.2147/JAA.S463572. eCollection 2025.
2
Effects of whey protein complex combined with low-intensity exercise in elderly inpatients with COPD at a stable stage.乳清蛋白复合物联合低强度运动对稳定期老年 COPD 住院患者的影响。
Asia Pac J Clin Nutr. 2023 Dec;32(4):375-382. doi: 10.6133/apjcn.202312_32(4).0001.
3
Evaluation of data processing pipelines on real-world electronic health records data for the purpose of measuring patient similarity.

本文引用的文献

1
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.美国胸科学会/欧洲呼吸学会官方声明:肺康复的关键概念和进展。
Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. doi: 10.1164/rccm.201309-1634ST.
2
A simple method to enable patient-tailored treatment and to motivate the patient to change behaviour.一种简单的方法,可以实现针对患者的治疗,并激励患者改变行为。
Chron Respir Dis. 2012;9(4):259-68. doi: 10.1177/1479972312459974.
3
Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
基于真实世界电子健康记录数据评估数据处理管道,以衡量患者相似度。
PLoS One. 2023 Jun 15;18(6):e0287264. doi: 10.1371/journal.pone.0287264. eCollection 2023.
4
Is it possible to reverse frailty in patients with chronic obstructive pulmonary disease?慢性阻塞性肺疾病患者的衰弱状态能否逆转?
Clinics (Sao Paulo). 2020 Oct 26;75:e1778. doi: 10.6061/clinics/2020/e1778. eCollection 2020.
5
Impact of Disease-Specific Fears on Pulmonary Rehabilitation Trajectories in Patients with COPD.特定疾病恐惧对慢性阻塞性肺疾病患者肺康复进程的影响。
J Clin Med. 2019 Sep 13;8(9):1460. doi: 10.3390/jcm8091460.
6
Pulmonary Rehabilitation Reduces Subjective Fatigue in COPD: A Responder Analysis.肺康复可减轻慢性阻塞性肺疾病患者的主观疲劳:一项应答者分析。
J Clin Med. 2019 Aug 20;8(8):1264. doi: 10.3390/jcm8081264.
7
Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases.慢性呼吸系统疾病肺康复的组织方面。
Respirology. 2019 Sep;24(9):838-843. doi: 10.1111/resp.13512. Epub 2019 Feb 27.
8
Fatigue in Chronic Respiratory Diseases: Theoretical Framework and Implications For Real-Life Performance and Rehabilitation.慢性呼吸道疾病中的疲劳:理论框架及其对实际生活表现和康复的影响
Front Physiol. 2018 Sep 19;9:1285. doi: 10.3389/fphys.2018.01285. eCollection 2018.
9
Physical Inactivity, Self-Management, and Living Well With COPD.缺乏身体活动、自我管理与慢性阻塞性肺疾病的良好生活状态
Am J Lifestyle Med. 2017 Apr 4;11(4):303-306. doi: 10.1177/1559827617700596. eCollection 2017 Jul-Aug.
10
COPD stands for complex obstructive pulmonary disease.COPD 代表慢性阻塞性肺疾病。
Eur Respir Rev. 2018 Jun 6;27(148). doi: 10.1183/16000617.0027-2018. Print 2018 Jun 30.
西班牙慢性阻塞性肺疾病指南(GesEPOC):稳定期 COPD 的药物治疗。西班牙肺病学和胸外科学会。
Arch Bronconeumol. 2012 Jul;48(7):247-57. doi: 10.1016/j.arbres.2012.04.001. Epub 2012 May 3.
4
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.血液嗜酸性粒细胞指导慢性阻塞性肺疾病加重的皮质类固醇治疗:一项随机安慰剂对照试验。
Am J Respir Crit Care Med. 2012 Jul 1;186(1):48-55. doi: 10.1164/rccm.201108-1553OC. Epub 2012 Mar 23.
5
An official American Thoracic Society workshop report: the Integrated Care of The COPD Patient.美国胸科学会官方专题研讨会报告:慢性阻塞性肺疾病患者的综合护理。
Proc Am Thorac Soc. 2012 Mar;9(1):9-18. doi: 10.1513/pats.201201-014ST.
6
Self-management programmes for COPD: moving forward.慢性阻塞性肺疾病的自我管理方案:持续推进。
Chron Respir Dis. 2012 Feb;9(1):27-35. doi: 10.1177/1479972311433574.
7
Controversies in treatment of chronic obstructive pulmonary disease.慢性阻塞性肺疾病治疗的争议。
Lancet. 2011 Sep 10;378(9795):1038-47. doi: 10.1016/S0140-6736(11)61295-6.
8
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.慢性阻塞性肺疾病急性加重:生物簇及其生物标志物的鉴定。
Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71. doi: 10.1164/rccm.201104-0597OC.
9
Towards individualised treatment in COPD.迈向慢性阻塞性肺疾病的个体化治疗。
Thorax. 2011 May;66(5):363-4. doi: 10.1136/thx.2010.155564. Epub 2011 Jan 19.
10
Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes.识别和前瞻性验证具有临床相关性的慢性阻塞性肺疾病(COPD)亚型。
Thorax. 2011 May;66(5):430-7. doi: 10.1136/thx.2010.154484. Epub 2010 Dec 21.